In: The Journal of Clinical Endocrinology & Metabolism, 2016, vol. 101, no. 12, p. 5004-5011
|
In: Cell and Tissue Research, 2015, vol. 359, no. 3, p. 841-851
|
In: Human reproduction update, ///-
|
In: Human Reproduction, 2016, vol. 31, no. 10, p. 2160-2163
|
In: The Journal of Clinical Endocrinology & Metabolism, 2018, vol. 103, no. 5, p. 1948-1957
|
In: Journal of Hematopathology, 2015, vol. 8, no. 1, p. 13-20
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1213-1220
|
In: Social Psychiatry and Psychiatric Epidemiology, 2015, vol. 50, no. 12, p. 1831-1841
|
In: Human Reproduction, 2016, vol. 31, no. 9, p. 2031-2041
|
In: Blood, 2020, vol. 135, no. 21, p. 1859–1869
Most patients with chronic lymphocytic leukemia (CLL) are diagnosed with early-stage disease and managed with active surveillance. The individual course of patients with early-stage CLL is heterogeneous, and their probability of needing treatment is hardly anticipated at diagnosis. We aimed at developing an international prognostic score to predict time to first treatment (TTFT) in patients...
|